Subtype
Malignant Intestinal Neoplasm
CI-CAN-00001137Explore in graph →
1,666 active trials21 approved drugs383 evidence items
- NCIt
- C4572
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001137Explore in graph →
Clinical trials
7,771 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (772)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04465214 | Mobile Sensor Technologies to Assess General Symptomology of People With Cancer | completed | — | 49 | National Cancer Institute (NCI)NIH | 1 | Aug 17, 2026 | clinicaltrials |
| NCT04942626 | Capecitabine-based Chemoradiotherapy in Combination With the IL-1 Receptor Antagonist Anakinra for Rectal Cancer Patients(ACO/ARO/AIO-21) | completed | Phase 1 | 12 | Goethe UniversityOTHER | 1 | Aug 17, 2026 |
| clinicaltrials |
| NCT05510908 | Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC | completed | — | 460 | AIDS Malignancy ConsortiumNETWORK | 2 | Aug 14, 2026 | clinicaltrials |
| NCT04354246 | COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies | completed | Phase 1 | 94 | Compugen LtdINDUSTRY | 1 | Aug 12, 2026 | clinicaltrials |
| NCT06323421 | Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer(MindCRC) | completed | N/A | 24 | University of Illinois at ChicagoOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT06593678 | Telerehabilitation in Cancer Patients: Optimization of Prehabilitation and Rehabilitation Following Colorectal Resection(CCR) | completed | N/A | 80 | Instituto de Investigación Sanitaria AragónOTHER | 1 | Aug 11, 2026 | clinicaltrials |
| NCT00265850 | Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer | completed | Phase 3 | 2,334 | Alliance for Clinical Trials in OncologyOTHER | 2 | Aug 7, 2026 | clinicaltrials |
| NCT04104139 | TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer | completed | Phase 1 | 19 | OHSU Knight Cancer InstituteOTHER | 1 | Aug 6, 2026 | clinicaltrials |
| NCT01394939 | Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma | completed | Phase 1 / Phase 2 | 52 | Jennerex BiotherapeuticsINDUSTRY | 3 | Aug 5, 2026 | clinicaltrials |
| NCT02970513 | Psychological Evaluation According Colonic Colonization by Escherichia Coli of Patients After Colorectal Surgery(MicrobioPSY) | completed | N/A | 12 | University Hospital, Clermont-FerrandOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06714292 | Fluorescent Approach for Refined Endoscopic Marking With Clip Localization and Identification Procedure(FLARECLIP) | completed | Phase 2 | 110 | Seoul National University HospitalOTHER | 1 | Aug 5, 2026 | clinicaltrials |
| NCT06908031 | SCRT+mFOLFOX6+PD-1 Antibody and Targeted Therapy for High-Risk pMMR/MSS Rectal Cancer(CRIT) | completed | Phase 2 | 49 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Aug 4, 2026 | clinicaltrials |
| NCT06068257 | Tumor-Derived FGF19 | completed | — | 119 | University of Central FloridaOTHER | 1 | Jul 30, 2026 | clinicaltrials |
| NCT07736131 | Learning Curve of SILS in CRC(SILS) | completed | — | 280 | Ruijin HospitalOTHER | 0 | Jul 30, 2026 | clinicaltrials |
| NCT07725692 | Predictors of Rescue Surgery, Mortality, and Permanent Stoma After Anastomotic Leak Following Colorectal Cancer Resection(leak predictor) | completed | — | 3,200 | Alexandria UniversityOTHER | 1 | Jul 24, 2026 | clinicaltrials |
| NCT02821559 | Biweekly Versus Triweekly Raltitrexed With Oxaliplatin (With or Without Bevacizumab) in First-line Metastatic Colorectal Cancer(EROS) | completed | Phase 2 | 37 | Centre Hospitalier Universitaire de BesanconOTHER | 1 | Jul 23, 2026 | clinicaltrials |
| NCT05198934 | Sotorasib and Panitumumab Versus Investigator's Choice for Participants With Kirsten Rat Sarcoma (KRAS) p.G12C Mutation(CodeBreak300) | completed | Phase 3 | 160 | AmgenINDUSTRY | 12 | Jul 22, 2026 | clinicaltrials |
| NCT03958747 | Ultrasound for the Detection of Oxaliplatin-Induced Peripheral Neuropathy | completed | N/A | 20 | Wake Forest University Health SciencesOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT07180303 | Colorectal Cancer Screening in Chinese Rural Communities(SMART-CRC) | completed | N/A | 20,026 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 21, 2026 | clinicaltrials |
| NCT05128032 | Pressure-enabled Delivery in Radioembolization (TriNav Study)(PEDIR) | completed | N/A | 29 | Massachusetts General HospitalOTHER | 1 | Jul 20, 2026 | clinicaltrials |
| NCT07709923 | Predictive Model For Anastomotic Leakage After Colorectal Cancer Surgery(Doesn't exist) | completed | — | 117 | University of FoggiaOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT05396300 | A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors | completed | Phase 1 | 58 | Weijia Fang, MDOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT05453630 | Colonoscopy Outreach for Rural Communities Aim 2 | completed | N/A | 527 | University of WashingtonOTHER | 1 | Jul 15, 2026 | clinicaltrials |
| NCT03705897 | PROSPR Project 1: Identifying and Tracking Personalized CRC Screening Regimens for Patients in Clinical Settings | completed | N/A | 9,264 | University of Texas Southwestern Medical CenterOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT05840263 | Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer | completed | — | 48 | University of Colorado, DenverOTHER | 1 | Jul 14, 2026 | clinicaltrials |
| NCT05538195 | Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors | completed | Phase 1 / Phase 2 | 17 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Jul 10, 2026 | clinicaltrials |
| NCT02009449 | A Phase 1 Study of Pegilodecakin (LY3500518) in Participants With Advanced Solid Tumors(IVY) | completed | Phase 1 | 353 | Eli Lilly and CompanyINDUSTRY | 1 | Jul 9, 2026 | clinicaltrials |
| NCT05415475 | Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors | completed | Phase 1 | 30 | Chongqing Precision Biotech Co., LtdINDUSTRY | 1 | Jul 9, 2026 | clinicaltrials |
| NCT01380600 | Phase 1b Dose Escalation Study of Intravenous JX-594 in Metastatic, Refractory Colorectal Carcinoma | completed | Phase 1 | 15 | Jennerex BiotherapeuticsINDUSTRY | 1 | Jul 8, 2026 | clinicaltrials |
| NCT03879109 | Chemotherapy Followed by Pelvic Reirradiation Versus Chemotherapy Alone as Pre-operative Treatment for Locally Recurrent Rectal Cancer(GRECCAR15) | completed | Phase 3 | 58 | University Hospital, BordeauxOTHER | 1 | Jul 8, 2026 | clinicaltrials |
| NCT03345563 | Project HERO: Health Empowerment & Recovery Outcomes(HERO) | completed | N/A | 113 | Rutgers, The State University of New JerseyOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT03491709 | A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC | completed | Phase 1 | 18 | Dragonboat Biopharmaceutical Company LimitedINDUSTRY | 1 | Jul 6, 2026 | clinicaltrials |
| NCT04000880 | Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health(AMPLIFY) | completed | N/A | 603 | University of Alabama at BirminghamOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT05632744 | Evaluation of CG-100 Intraluminal Bypass Device | completed | N/A | 7 | Colospan Ltd.INDUSTRY | 1 | Jul 2, 2026 | clinicaltrials |
| NCT06370949 | The Effectiveness of Bupivacaine and Bupivacaine+Dexmedetomidine Combination in Transversus Abdominis Plane* Block(TAP) | completed | — | 84 | Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research HospitalOTHER | 1 | Jul 2, 2026 | clinicaltrials |
| NCT04895137 | mFOLFOX6+Bevacizumab+PD-1 Monoclonal Antibody in Local Advanced MSS CRC(BASKETⅡ) | completed | Phase 2 | 42 | Sixth Affiliated Hospital, Sun Yat-sen UniversityOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT07678099 | Screening Colonoscopy in Breast Cancer Patients | completed | N/A | 216 | Haydarpasa Numune Training and Research HospitalOTHER | 1 | Jul 1, 2026 | clinicaltrials |
| NCT02891538 | Chemopreventive Effects of Epigallocatechin Gallate (EGCG) in Colorectal Cancer (CRC) Patients | completed | Early Phase 1 | 51 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 30, 2026 | clinicaltrials |
| NCT04287868 | Combination Immunotherapy in Subjects With Advanced HPV Associated Malignancies | completed | Phase 1 / Phase 2 | 51 | National Cancer Institute (NCI)NIH | 1 | Jun 30, 2026 | clinicaltrials |
| NCT06340503 | Evaluating a Physical Activity Index for Assessment and Counseling for Breast and Colon Cancer Survivors | completed | N/A | 20 | Wake Forest University Health SciencesOTHER | 1 | Jun 29, 2026 | clinicaltrials |
| NCT06096623 | The Care Tracker Study: Using Patient-Reported Data to Address Racial Disparity in Cancer Treatment | completed | — | 100 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2026 | clinicaltrials |
| NCT05185947 | Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis | completed | Phase 2 | 21 | National Cancer Institute (NCI)NIH | 1 | Jun 25, 2026 | clinicaltrials |
| NCT06884670 | Assessment of Efficacy and Safety of PD-1 Monoclonal Antibody Combined With IL-2 and CapeOX in Neoadjuvant Therapy for Locally Advanced Rectal Cancer Prior to Surgery: A Prospective, Multi-center, Randomized Controlled Study | completed | Phase 2 | 130 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jun 24, 2026 | clinicaltrials |
| NCT00079274 | Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer | completed | Phase 3 | 3,397 | National Cancer Institute (NCI)NIH | 3 | Jun 23, 2026 | clinicaltrials |
| NCT02515344 | Impact of the Distribution to Attending Physicians of a Nominative List of Their Patients Not Participating in the Organised Screening of Colorectal Cancer(IDLN) | completed | N/A | 48,649 | Nantes University HospitalOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT04323722 | Impact of Bladder Depletion on Mesorectal Movements During Radiotherapy in Rectal Cancer(MESORECT-VV) | completed | N/A | 53 | Institut Cancerologie de l'OuestOTHER | 1 | Jun 23, 2026 | clinicaltrials |
| NCT04457284 | Temozolomide, Cisplatin, and Nivolumab in People With Colorectal Cancer | completed | Phase 2 | 18 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 18, 2026 | clinicaltrials |
| NCT07653737 | Immunonutrition for Prehabilitation of Patients With Colorectal Cancer Before Surgery(IMNUTPREH-CRC) | completed | N/A | 56 | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y CajalOTHER | 1 | Jun 17, 2026 | clinicaltrials |
| NCT05379205 | Multidisciplinary Prehabilitation and Postoperative Rehabilitation in Patients Undergoing Resection of Colon Cancer(ONCOFIT) | completed | N/A | 90 | Universidad de GranadaOTHER | 1 | Jun 16, 2026 | clinicaltrials |
Data updated 22 days agoSource updated Aug 17, 2026source: clinicaltrials